Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 3]
Phase 3 clinical trial evaluating a three-drug combination of Bleximenib, Venetoclax, and Azacitidine for newly diagnosed acute myeloid leuk…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib [Phase 1, Phase 2]
A multi-site Phase I/II trial at MD Anderson Cancer Center is evaluating the combination of venetoclax (BCL-2 inhibitor) and revumenib (meni…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and in combination with ipilimumab, nivolumab…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML [Phase 2]
Phase 2 clinical trial evaluating venetoclax in combination with cladribine and cytarabine alternating with azacitidine plus venetoclax for …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 trial assessing addition of M3814 (peposertib) to the standard mitoxantrone, etoposide, and cytarabine regimen for relapsed or refra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial evaluating a three-drug combination (bortezomib, sorafenib tosylate, and decitabine) in adults with acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia [Phase 1]
A Phase 1 pediatric trial aims to identify the highest tolerated dose of a cedazuridine-decitabine combination with filgrastim after hematop…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]
This Phase 1 clinical trial investigates the combination of targeted radiotherapy with Venetoclax and ASTX-727 for adults with newly diagnos…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia [Phase 1]
A Phase 1 clinical trial evaluating a radiolabeled 14C-Bleximenib in patients with acute leukemia. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies [Phase 1]
This document reports on the status update for a Phase 1 trial of Bleximenib in combination with AML-directed therapies for acute myeloid le…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) [Phase 2]
A Phase 2 clinical trial update evaluating different Venetoclax treatment durations in older adults with newly diagnosed acute myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) [Phase 1, Phase 2]
Phase I/II trial evaluating an engineered donor graft named Orca Q for pediatric hematopoietic cell transplantation is currently suspended. …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring [Phase 1]
Phase 1 rollover study by Janssen Research & Development to continue study treatment and ongoing safety monitoring in patients with acute my…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute's Cancer Moonshot Biobank update outlines the trial's status and scope, indicating the study is active but not rec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy [Phase 1]
Phase 1 clinical trial sponsored by the University of Alabama at Birmingham evaluating UAB 2419-CD34 selection using the CliniMACS Prodigy s…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial) [Phase 2]
Phase 2 ERASE trial update exploring combination therapy for persistent low-level acute myeloid leukemia after initial treatment; the study …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial evaluating the combination of decitabine, cytarabine, and daunorubicin hydrochloride for treatment of Acute Myeloid…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating adaptive dual-target CAR-T cell therapy for relapsed or refractory hematologic malignancies; recru…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy) [Phase 2]
Clinical trial update outlining plans to study IDH1 inhibitor olutasidenib in combination with ASTX727 and venetoclax for acute myeloid leuk…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia [Phase 1]
Phase 1 clinical trial update evaluating the addition of navtemadlin to standard cytarabine and idarubicin in patients with acute myeloid le…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML [Phase 1]
Phase 1 trial update testing the combination of iadademstat with venetoclax and azacitidine for acute myeloid leukemia is currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts [Phase 1]
Phase 1 clinical trial evaluating TAK-243 for relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes with increased bla…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial is testing KRT-232 (AMG-232) in combination with Decitabine and Venetoclax for Acute Myeloid Leukemia. The study is…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes [Phase 1]
Phase 1 clinical trial update indicating GLB-001 is being studied in relapsed or refractory Acute Myeloid Leukemia and relapsed or refractor…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms [Phase 1]
This is a Phase 1 clinical-trial update for JNJ-90189892 in relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasms, curr…